FEEDBACK
PLEASE WAIT ...
CLOSE
CLOSE

Country

Certificates

FDA
Registration Date 16 Nov 2016
Share

LIPODOX

Medicine Pharmaceuticals Product Number : 47335-082-50

Antineoplastic Agent

Drug Information

NDC Code
47335-082-50
Drug Class
Anthracycline Topoisomerase Inhibitor
Therapeutic Class
Antineoplastic Agent
Dosage form
Solution
Route of Administration
Intravenous Injection
Therapeutic Area
1.treatment of various cancers like advanced breast cancer, advanced ovarian cancer, progressive multiple myeloma, AIDS related Kaposi’s sarcoma.

Indication

Doxorubicin liposome injection is used to treat ovarian cancer and Kaposi sarcoma (AIDS patients). It is also used together with bortezomib to treat multiple myeloma. Doxorubicin liposome is an antineoplastic agent (cancer medicine). Doxorubicin liposome interferes with the growth of cancer cells, which are eventually destroyed by the body. Since the growth of normal body cells may also be affected by doxorubicin liposome, other unwanted side effects will also occur. Some of these may be serious and must be reported to your doctor.